Uber, TransDigm and Insulet Screen as Quality Compounder Stocks to Watch

Uber Technologies, TransDigm Group and Insulet were highlighted May 14, 2026, as “quality compounder” stocks, based on profit reinvestment potential and long-term business momentum. Uber (NYSE: UBER), with a market capitalization of $153.6 billion, was cited for its ride-hailing, delivery and freight platform. The stock was listed at $75.45, implying 13.9 times forward EV/EBITDA. TransDigm (NYSE: TDG), valued at $67.96 billion, was noted for its aviation components business serving commercial and military aircraft. Shares were quoted at $1,238, or 28.6 times forward earnings. Insulet (NASDAQ: PODD), with a market value of $10.68 billion, was cited for its Omnipod insulin delivery systems. Its shares were listed at $157.22, implying 24.1 times forward earnings.